Syncona Portfolio Ltd
- SEC CIK
- 0001725042
- Latest filing
- Aug 6, 2026
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 31, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 4
- 0 vs. Q4 2021
- Portfolio value
- $104.7M
- $0 (0.0%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 11,086,909 | $55.5M | 53.1% | 00.0% | Unchanged | – |
| AUTLAutolus Therapeutics plc | SPON ADS | 7,346,829 | $38.1M | 36.4% | 00.0% | Unchanged | History |
| Freeline Therapeutics Hldgs35655L107 | SPONSORED ADS | 21,997,620 | $5.84M | 5.6% | +19,047,620+645.7% | Added | – |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 1,377,294 | $5.17M | 4.9% | 00.0% | Unchanged | History |